<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04416971</url>
  </required_header>
  <id_info>
    <org_study_id>Mature Fistulas</org_study_id>
    <nct_id>NCT04416971</nct_id>
  </id_info>
  <brief_title>Clinical Values of Mature Fistulas in Hemodialysis</brief_title>
  <official_title>Clinical Values of Mature Fistulas in Hemodialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Zhongshan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Zhongshan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis(HD), and
      fistula-first is the general recommendation for all HD patients. But in clinical practice in
      China, quite a few patients start HD before AVF maturation due to various situations. Whether
      HD initiation with mature AVF will influence the patency and complications is controversial.
      This study is aim to compare the AVF patency in incident HD patients with mature or immature
      AVF on HD initiation, and to compare other clinical outcomes, including abandonment without
      use, infection, and other AVF complications occurrence.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2020</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>AVF patency</measure>
    <time_frame>June 2020 to June 2021</time_frame>
    <description>A functional AVF was defined as allowing at least six adequate HD sessions without any AVF-related complications. Primary AVF patency was defined as the interval from HD initiation via a functional AVF to any intervention designed for maintenance or reestablishment of AVF function, AVF failure, or study end, whichever occurred first, and secondary AVF patency was defined as the interval from HD initiation via an AVF until the termination of HD via AVF due to any cause, regardless of the number of subsequent interventions.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Abandonment without use, infection, and other complications of AVF creation.</measure>
    <time_frame>June 2020 to June 2021</time_frame>
    <description>Abandonment without use, infection, and other complications of AVF creation.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hemodialysis Access Failure</condition>
  <condition>Hemodialysis Complication</condition>
  <arm_group>
    <arm_group_label>mature AVF</arm_group_label>
    <description>Patients initiate HD with mature AVF.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>immature AVF</arm_group_label>
    <description>Patients initiate HD with immature AVF.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>AVF puncture</intervention_name>
    <description>For patients with mature/immature AVF on HD initiation, AVF puncture will be conducted.</description>
    <arm_group_label>immature AVF</arm_group_label>
    <arm_group_label>mature AVF</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  aged 18 years and older

          -  underwent initial upper-extremity AVF creation for incident HD at our hospital

          -  divided into mature/immature AVF groups according to the AVF status on HD initiation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  underwent initial upper-extremity AVF creation for incident HD at Zhongshan Hospital,
             Fudan University

        Exclusion Criteria:

          -  with malignancies

          -  not followed-up at Zhongshan Hospital, Fudan University
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 1, 2020</study_first_submitted>
  <study_first_submitted_qc>June 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shanghai Zhongshan Hospital</investigator_affiliation>
    <investigator_full_name>Bo Shen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

